News

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...
There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts. It's become available ...
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...
Nearly 90 percent of Dutch citizens believe that obesity medication should be covered by the basic health insurance package, ...
A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?
The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...
Professor of Public Health Grant Scofield joins Emile Donovan to discuss the effectiveness of Wegovy and Ozempic, and whether ...
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
With the recent approval in China of Innovent Biologics' (OTCPK:IVBIY) mazdutide as the first-ever dual GLP-1/glucagon ...
These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...